RxDoctor Payments Data

Sanford Herman

Psychiatry · Jamaica, NYNPI 1689720187

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $600,237 of the $745,667 with a category attached, or 80.5%. Johnson & Johnson accounts for 92.0% of it on its own, with 2 other manufacturers making up the rest. Among psychiatry clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$745,667in general payments, 2019–2025

Across 864 payments — averaging $863.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$686K
  • E.r. Squibb & Sons, L.L.C.$59K
  • Alkermes, Inc.$470

What the payments were for

  • Consulting fees$19,3953%
  • Speaking & faculty fees$600,23780%
  • Travel & lodging$111,38215%
  • Food & beverage$14,6542%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson799$686,355
E.r. Squibb & Sons, L.L.C.61$58,842
Alkermes, Inc.4$470

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$745,667 in reported general payments places this provider in the 95th percentile of 3,713 psychiatry providers in New York.

See all psychiatry providers in New York →

Other psychiatry in Jamaica

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →